Correlation Between Centessa Pharmaceuticals and Dividend

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Dividend at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Dividend into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Dividend 15 Split, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Dividend and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Dividend. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Dividend.

Diversification Opportunities for Centessa Pharmaceuticals and Dividend

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Centessa and Dividend is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Dividend 15 Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dividend 15 Split and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Dividend. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dividend 15 Split has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Dividend go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Dividend

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 5.55 times more return on investment than Dividend. However, Centessa Pharmaceuticals is 5.55 times more volatile than Dividend 15 Split. It trades about 0.06 of its potential returns per unit of risk. Dividend 15 Split is currently generating about 0.22 per unit of risk. If you would invest  1,551  in Centessa Pharmaceuticals PLC on October 7, 2024 and sell it today you would earn a total of  150.00  from holding Centessa Pharmaceuticals PLC or generate 9.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy96.92%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Dividend 15 Split

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Dividend 15 Split 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Dividend 15 Split are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Dividend may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Centessa Pharmaceuticals and Dividend Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Dividend

The main advantage of trading using opposite Centessa Pharmaceuticals and Dividend positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Dividend can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dividend will offset losses from the drop in Dividend's long position.
The idea behind Centessa Pharmaceuticals PLC and Dividend 15 Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets